UF Health and fitness joins countrywide study to examination COVID-19 treatment options

GAINESVILLE, Fla. – Scientists at College of Florida Health and fitness and the OneFlorida+ Clinical Analysis Network have begun recruiting sufferers to a countrywide analyze to discover if a number of current prescription and about-the-counter drugs can support all those with COVID-19 safely and securely handle their signs and symptoms at household and avoid hospitalization.

Advert

The study is one particular of a number of exploration jobs that are part of the Accelerating COVID‑19 Therapeutic Interventions and Vaccines, or ACTIV, general public-private partnership funded by the Nationwide Institutes of Wellbeing. The ACTIV-6 review will check out a number of medication currently accredited by the U.S. Food items and Drug Administration for other situations — an solution called drug repurposing — to test the drugs’ security and performance in treating COVID-19.

Ad

At the moment, no therapies have been approved by the Food and drug administration particularly to handle COVID-19 indicators these as exhaustion, shortness of breath, fever, cough, nausea, vomiting, diarrhea, body aches, chills, headache, sore throat, nasal congestion or reduction of feeling of flavor or scent.

“In the ACTIV-6 review, we’ll be tests a choose team of current medicine that are Fda accepted for other situations, that by now have an proven basic safety document and that have demonstrated early indications of success against the symptoms of COVID-19 in modest, preliminary experiments,” explained Elizabeth A. Shenkman, chair of the section of overall health outcomes and biomedical informatics in the Higher education of Medicine at UF and co-principal investigator of the OneFlorida+ Medical Investigation Community. “Our primary objective is to detect which of people prescription drugs can aid folks experience better faster and continue to keep them out of the healthcare facility.”

Advertisement

Shenkman serves as the UF Health web page principal investigator for ACTIV-6. Dr. Christina Li, an assistant professor in the UF Faculty of Medicine’s division of internal drugs, serves as the UF Overall health medical doctor web page principal investigator.

Advertisement

Shenkman mentioned the analyze group to begin with will exam three medications that have revealed early indications of efficacy in opposition to COVID-19 in preliminary studies: fluticasone, an inhaled steroid typically utilized to handle asthma and persistent obstructive pulmonary disease…